Gujarat Themis Biosyn Limited — Others, 01-08-2025: Change in Director(s)

Gujarat Themis Biosyn's board has approved the financial results for the quarter, reporting a net profit of 9.06 Cr and total income of 36.15 Cr. The company has fixed September 5 as the record date for the dividend for the last financial year. Strategically, the board decided not to proceed with the proposed merger with Themis Medicare Limited, choosing instead to focus on its core business of fermentation-based pharmaceutical intermediates. Operationally, the new state-of-the-art API plant in Vapi commenced commercial production, aiming to bolster forward integration and export market presence. Mr. Nihar Parikh was appointed as an Independent Director, replacing Mr. Siddharth Kusumgar.